Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment

NCT05514756 is registered in ClinicalTrials.gov with Tallaght University Hospital as lead sponsor.

NCT NCT05514756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment
Lead sponsor
Tallaght University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2022
Completion date
June 30, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, inflammatory response, memory impairment, mild cognitive impairment, neurocardiogenic syncope